Australian govt deal with industry delivering lower medicine prices

25 July 2012

Inflation figures released yesterday by the Australian Bureau of Statistics (ABS) measuring the Consumer Price Index (CPI) show that this rose 0.5% in the June quarter, for an annual rate of 1.2%. The headline annual inflation figure to June was well below the Reserve Bank of Australia's (RBA) target band of two to three per cent, but underlying inflation, which smoothes out the larger quarterly prices movements, was two per cent for the year to June.

The most significant price rises in the June quarter 2012 were for medical and hospital services (+2.8%), rents (+1.1%), vegetables (+5.2%) and furniture (+4.5%), but there was a big fall in the prices consumers pay for medicines.

Commenting on the figures, Medicines Australia chief executive Brendan Shaw said that this fall showed that the Memorandum of Understanding between Medicines Australia and the Government for the Pharmaceutical Benefits Scheme is working.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical